Ποια είναι η τιμή για Anteris Technologies Global Corp. (AVR)

Η τιμή για Anteris Technologies Global Corp. (AVR) είναι $8.88

Ποια είναι η κεφαλαιοποίηση αγοράς για Anteris Technologies Global Corp. (AVR)

Η κεφαλαιοποίηση αγοράς για Anteris Technologies Global Corp. (AVR) είναι $863.29M

Anteris Technologies Global Corp. (AVR) Τιμή και Κεφαλαιοποίηση Αγοράς

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Η τιμή για AVR	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$54,137.16 $863.29M	NVDA	$5.264T	+609,642.00%
$48,351.09 $863.29M	AAPL	$4.701T	+544,473.98%
$42,960.91 $863.29M	GOOG	$4.177T	+483,764.88%
$39,260.73 $863.29M	MSFT	$3.817T	+442,090.02%
$29,479.34 $863.29M	AMZN	$2.866T	+331,923.16%

Η τιμή για AVR

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$54,137.16 $863.29M